85 related articles for article (PubMed ID: 18635189)
1. Circulating oxidized LDL, measured with FOH1a/DLH3 antibody, is associated with metabolic syndrome and the coronary heart disease risk score in healthy Japanese.
Ueba T; Nomura S; Nishikawa T; Kajiwara M; Yamashita K
Atherosclerosis; 2009 Mar; 203(1):243-8. PubMed ID: 18635189
[TBL] [Abstract][Full Text] [Related]
2. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
Wu T; Willett WC; Rifai N; Shai I; Manson JE; Rimm EB
J Am Coll Cardiol; 2006 Sep; 48(5):973-9. PubMed ID: 16949489
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the Cardiovascular Risk in Young Finns study.
Koskinen J; Magnussen CG; Würtz P; Soininen P; Kangas AJ; Viikari JS; Kähönen M; Loo BM; Jula A; Ahotupa M; Lehtimäki T; Ala-Korpela M; Juonala M; Raitakari OT
Eur J Prev Cardiol; 2012 Dec; 19(6):1296-303. PubMed ID: 21960651
[TBL] [Abstract][Full Text] [Related]
4. Oxidized LDL and anti-oxLDL antibody levels in peripheral atherosclerotic disease.
Andican G; Seven A; Uncu M; Cantaşdemir M; Numan F; Burçak G
Scand J Clin Lab Invest; 2008; 68(6):473-8. PubMed ID: 18609113
[TBL] [Abstract][Full Text] [Related]
5. Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the Health, Aging, and Body Composition study.
Holvoet P; Harris TB; Tracy RP; Verhamme P; Newman AB; Rubin SM; Simonsick EM; Colbert LH; Kritchevsky SB
Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1444-8. PubMed ID: 12791672
[TBL] [Abstract][Full Text] [Related]
6. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease.
Toshima S; Hasegawa A; Kurabayashi M; Itabe H; Takano T; Sugano J; Shimamura K; Kimura J; Michishita I; Suzuki T; Nagai R
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2243-7. PubMed ID: 11031210
[TBL] [Abstract][Full Text] [Related]
7. Circulating oxidized LDL is associated with parameters of the metabolic syndrome in postmenopausal women.
Lapointe A; Couillard C; Piché ME; Weisnagel SJ; Bergeron J; Nadeau A; Lemieux S
Atherosclerosis; 2007 Apr; 191(2):362-8. PubMed ID: 16677652
[TBL] [Abstract][Full Text] [Related]
8. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population.
Meisinger C; Baumert J; Khuseyinova N; Loewel H; Koenig W
Circulation; 2005 Aug; 112(5):651-7. PubMed ID: 16043640
[TBL] [Abstract][Full Text] [Related]
9. Plasma level of platelet-derived microparticles is associated with coronary heart disease risk score in healthy men.
Ueba T; Nomura S; Inami N; Nishikawa T; Kajiwara M; Iwata R; Yamashita K
J Atheroscler Thromb; 2010 Apr; 17(4):342-9. PubMed ID: 20379056
[TBL] [Abstract][Full Text] [Related]
10. Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients.
Girona J; Manzanares JM; Marimón F; Cabré A; Heras M; Guardiola M; Ribalta J; Masana L
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):380-7. PubMed ID: 17904830
[TBL] [Abstract][Full Text] [Related]
11. Comparison of metabolic syndrome subjects with and without erectile dysfunction - levels of circulating oxidised LDL and arterial elasticity.
Pohjantähti-Maaroos H; Palomäki A
Int J Clin Pract; 2011 Mar; 65(3):274-80. PubMed ID: 21314864
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of oxidized low density lipoprotein are associated with stable angina pectoris and modalities of acute coronary syndrome.
Imazu M; Ono K; Tadehara F; Kajiwara K; Yamamoto H; Sumii K; Tasaki N; Oiwa J; Shimohara Y; Gomyo Y; Itabe H
Int Heart J; 2008 Sep; 49(5):515-24. PubMed ID: 18971563
[TBL] [Abstract][Full Text] [Related]
13. Arterial elasticity and oxidized LDL among men with metabolic syndrome and different 10-year cardiovascular risk estimated by FINRISK and SCORE models.
Pohjantähti-Maaroos H; Palomäki A; Kankkunen P; Husgafvel S; Knuth T; Vesterinen K; Oksanen K
Ann Med; 2012 Aug; 44(5):503-12. PubMed ID: 21726125
[TBL] [Abstract][Full Text] [Related]
14. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort.
Holvoet P; Kritchevsky SB; Tracy RP; Mertens A; Rubin SM; Butler J; Goodpaster B; Harris TB
Diabetes; 2004 Apr; 53(4):1068-73. PubMed ID: 15047623
[TBL] [Abstract][Full Text] [Related]
15. Coronary disease risk prediction algorithm warranting incorporation of C-reactive protein in Turkish adults, manifesting sex difference.
Onat A; Can G; Hergenç G; Uğur M; Yüksel H
Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):643-50. PubMed ID: 21315565
[TBL] [Abstract][Full Text] [Related]
16. Oxidized LDL and coronary heart disease.
Holvoet P
Acta Cardiol; 2004 Oct; 59(5):479-84. PubMed ID: 15529550
[TBL] [Abstract][Full Text] [Related]
17. A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-year-old men and women.
Tonstad S; Hjermann I
J Cardiovasc Risk; 2003 Apr; 10(2):129-35. PubMed ID: 12668910
[TBL] [Abstract][Full Text] [Related]
18. Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary artery disease.
Shimada K; Mokuno H; Matsunaga E; Miyazaki T; Sumiyoshi K; Miyauchi K; Daida H
Atherosclerosis; 2004 Jun; 174(2):343-7. PubMed ID: 15136065
[TBL] [Abstract][Full Text] [Related]
19. Elevated oxidized low-density lipoprotein concentrations in postmenopausal women with the metabolic syndrome.
Park SH; Kim JY; Lee JH; Park HY
Clin Chim Acta; 2011 Feb; 412(5-6):435-40. PubMed ID: 21093421
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
